COVID-19 Vaccine Daily Bulletin No. 140

NATIONAL COVID-19 VACCINATION OPERATIONS CENTER
AFP Commissioned Officers Club House, Camp Aguinaldo
BULLETIN
BULLETINNO.
NO.
34
140 As of 20 July 2021 1800H
PHILIPPINES COVID-19
Vaccine Deployment and
Vaccination Campaign
TOTAL DOSES 15,616,562

ADMINISTERED
Priority Group A1 Expanded Priority Priority Group A2 Priority Group A3 Priority Group A4 Priority Group A5
Group A1 GRAND TOTAL
Workers in Outbound OFWs and Senior Individuals with Frontline Personnel in Poor TOTAL VACCINATED
Frontline Immediate Family Citizens Comorbidity Essential Sectors Population FILIPINOS
Health Services Members of HCW &
Additional A1
1ST 2,781,196 2,023,421 379,289 10,585,261

DOSE
1,584,497 325,035 3,491,823
COMPLETED 1
1,260,503 75,791 1,263,049 1,664,014 577,220 190,724 5,031,301
2 DOSES
0
As of 20 July 2021, a total of 15,616,562 doses of COVID-19 vaccines

have been administered either as first or second dose. Out of these,
10,585,261 eligible individuals were vaccinated with their 1st dose
COVID-19 vaccine and 5,031,301 eligible individuals received their
complete doses of COVID-19 vaccines.
There were 284,441 total doses of COVID-19 vaccines administered on

20 July 2021. Of which, 120,500 were administered as first doses (2,270
to Priority Group A1; 13,062 to Expanded Priority Group A1; 10,756
were to Priority Group A2; 31,679 to Priority Group A3; 49,795 to
Priority Group A4; and 12,938 to Priority Group A5) and 163,941 were
administered as second doses (13,659 to Priority Group A1; 34,128 to
Priority Group A2; 39,123 to Priority Group A3; 65,743 to Priority
Group A4; and 12,131 to Priority Group A5).
Disclaimer: Counts are NOT absolute and are subject to change

following further verification/validation/deduplications of coverage reports per Region.
PHILIPPINES COVID-19 VACCINE DEPLOYMENT AND VACCINATION CAMPAIGN As of 20 July 2021 1

A total of 10,585,261 first doses and 5,031,301 second doses of COVID-19 vaccines have been
administered to Priority Group A. Of which 6,559,295 were Sinovac, 2,547,367 were Astrazeneca,
189,806 were Gamaleya, 1,225,378 were Pfizer, and 63,415 were Moderna for the first doses. On the
other hand, 3,683,121 were Sinovac, 532,339 were Astrazeneca, 56,760 were Gamaleya, and 757,886
were Pfizer for the second doses. There were 1,195 administered doses of Janssen J&J vaccine (Table
1).
Table 1. Summary of Number of Vaccinated Priority Group A for First and Second Dose per Region as of 20 July 2021 6 PM
Cumulative
Cumulative Janssen Vaccinated
Moderna Gamaleya Pfizer
Sinovac (1st AstraZeneca Gamaleya Pfizer Vaccinated Sinovac (2nd AstraZeneca J&J
REGION (1st (2nd (2nd (GROUP A)
Dose) (1st Dose) (1st Dose) (1st Dose) (GROUP A) Dose) (2nd Dose) 1 Dose COMPLETED
Dose) Dose) Dose)
1ST DOSE
2ND DOSE
NCR 2,737,430 766,058 91,815 568,145 59,427 4,222,875 1,754,613 157,004 50,041 494,060 995 2,456,713
CAR 101,849 42,213 5,382 18,237 0 167,681 67,085 10,113 239 17,542 0 94,979
1 178,401 100,462 9,672 12,516 0 301,051 116,847 9,226 0 10,752 0 136,825
2 146,018 88,897 12,093 9,932 0 256,940 99,308 9,909 163 4,610 0 113,990
3 508,592 313,694 7,608 102,589 2,463 934,946 247,254 64,342 328 24,812 0 336,736
4A 850,190 353,564 16,230 227,140 1,276 1,448,400 366,970 75,673 2,556 49,250 0 494,449
Mimaropa 100,810 47,532 5,776 0 0 154,118 61,606 13,585 258 0 0 75,449
5 158,229 54,083 0 0 30 212,342 83,091 13,569 0 0 0 96,660
6 364,870 137,139 2,923 14,579 219 519,730 188,872 11,378 0 2,901 0 203,151
7 283,225 146,191 8,108 115,937 0 553,461 131,709 29,502 291 61,872 0 223,374
8 194,961 71,911 2,393 1,189 0 270,454 97,883 26,513 0 1,120 0 125,516
9 145,272 61,679 6,599 17,948 0 231,498 78,834 11,329 1,432 14,634 200 106,429
10 209,899 87,360 20,125 18,211 0 335,595 113,606 28,711 1,452 18,513 0 162,282
11 242,280 147,191 882 118,955 0 509,308 98,882 18,721 0 57,820 0 175,423
12 128,475 61,843 0 0 0 190,318 70,270 32,579 0 0 0 102,849
CARAGA 140,827 53,601 200 0 0 194,628 78,450 13,907 0 0 0 92,357
BARMM 67,967 13,949 0 0 0 81,916 27,841 6,278 0 0 0 34,119
PHIL 6,559,295 2,547,367 189,806 1,225,378 63,415 10,585,261 3,683,121 532,339 56,760 757,886 1,195 5,031,301
There were 1,584,497 frontline healthcare workers in the Philippines, or 97.42% of the 1,626,495
masterlisted eligible Priority Group A1 population, who have been vaccinated as of 20 July 2021. Of which,
978,090 were vaccinated with Sinovac, 597,900 received the AstraZeneca vaccine, 5,679 received
Gamaleya vaccine, 57,162 received Pfizer vaccine, and 112 received Moderna vaccines. There were
1,260,503 health care workers (HCWs) in the country who have already completed their 2-dose vaccine
series (Table 2).


Table 2. Vaccination Coverage – First Dose and 2nd Completed Dose, per region for Masterlisted Eligible Population Priority A1 as of 20 July
2021, 6 PM
Total Overall
Coverage Total Overall
Masterlisted Vaccinated
Priority FIRST Vaccinated Coverage
REGION (Priority Group A1 COMPLETED COMPLETED
DOSE
Group A1) FIRST 2 DOSES 2 DOSES
DOSE
NCR 301,749 290,324 96.21% 257,208 85.24%

CAR 45,349 45,349 100.00% 34,496 76.07%
1 87,409 87,409 100.00% 72,793 83.28%
2 65,040 60,886 93.61% 45,499 69.96%
3 150,916 150,916 100.00% 109,132 72.31%
4A 136,169 136,169 100.00% 119,263 87.58%
Mimaropa 46,120 45,400 98.44% 32,471 70.41%
5 85,506 85,506 100.00% 61,729 72.19%
6 129,459 123,148 95.13% 82,300 63.57%
7 131,781 122,389 92.87% 90,258 68.49%
8 82,047 82,047 100.00% 62,737 76.46%
9 56,773 52,005 91.60% 41,627 73.32%
10 84,733 84,733 100.00% 66,769 78.80%
11 84,692 84,692 100.00% 73,954 87.32%
12 60,333 60,333 100.00% 51,125 84.74%
CARAGA 56,968 51,740 90.82% 43,324 76.05%
BARMM 21,451 21,451 100.00% 15,818 73.74%
PHIL 1,626,495 1,584,497 97.42% 1,260,503 77.50%
*Masterlisted eligible population is based on the latest submission of the Centers of Health Development. Data on masterlisting may change as new developments take place.
Figure 1. Coverage of Vaccinated with First Dose Among Priority Group A1 as of 20 July 2021, 6 PM
There were 325,035 Expanded Priority Group A1 (A1.8: Outbound Overseas Filipino Workers and A1.9:
Immediate family members of healthcare workers) who were given first dose of COVID-19 vaccines. Of
which, NCR administered 100,220 doses, CAR with 4,517, Region 1 with 16,311, Region 2 with 4,526,
Region 3 with 12,069, Region 4A accomplished 78,031, Mimaropa with 2,474, Region 5 with 17,449,
Region 6 with 7,764, Region 7 with 12,808, Region 8 with 21,215, Region 9 with 11,067, Region 10 with
9,705, Region 11 with 17,292, Region 12 with 3,961, CARAGA with 1,244 and BARMM with 4,382
There were 75,791 Expanded Priority Group A1 in the country who have already completed their 2-dose
vaccine regimen (Table 3).


Table 3. Vaccination Accomplishment – First Dose and Second Dose, per region for Expanded Priority Group A1 as of 20 July 2021, 6 PM
Expanded Expanded
Priority Priority
REGION
Group A1 Group A1
First Dose Second Dose
NCR 100,220 46,220
CAR 4,517 3,624
1 16,311 890
2 4,526 112
3 12,069 536
4A 78,031 18,449
Mimaropa 2,474 25
5 17,449 545
6 7,764 1,023
7 12,808 0
8 21,215 1,347
9 11,067 2,886
10 9,705 71
11 17,292 0
12 3,961 6
CARAGA 1,244 57
BARMM 4,382 0
PHIL 325,035 75,791
There were 2,781,196 senior citizens (Priority Group A2) [Table 4], 3,491,823 individuals with
comorbidity (Priority Group A3) [Table 5], 2,023,421 frontline personnel in essential sectors both in
public and private sectors (Priority Group A4) [Table 6], and 379,289 poor population (Priority Group
A5) [Table 7] who received their 1st dose of vaccine against COVID-19. On the other hand, there were
1,263,049 senior citizens, 1,664,014 individuals with comorbidity, 577,220 frontline personnel in
essential sectors both in public and private sectors, and 190,724 in the poor population in the country
who have already completed their 2-dose Sinovac vaccine regimen (Table 4, 5 & 6) as of the above-
mentioned date.
Table 4. Vaccination Coverage for Sinovac, AstraZeneca, Gamaleya, Pfizer, and Moderna Vaccine (First Dose amd Second Completed Dose) for
Masterlisted Eligible Population Priority A2 as of 20 July 2021, 6 PM
Total Overall Total Overall

Masterlisted
Vaccinated Coverage Vaccinated Coverage
REGION (Priority
FIRST FIRST COMPLETEDCOMPLETED
Group A2)
DOSE DOSE 2 DOSES 2 DOSES
NCR 1,133,317 694,658 61.29% 460,835 40.66%

CAR 145,441 50,639 34.82% 27,596 18.97%
1 547,788 132,216 24.14% 44,854 8.19%
2 347,638 88,447 25.44% 33,806 9.72%
3 1,145,288 353,516 30.87% 126,410 11.04%
4A 1,117,556 486,069 43.49% 195,069 17.45%
Mimaropa 270,797 56,955 21.03% 24,849 9.18%
5 472,205 59,439 12.59% 21,624 4.58%
6 793,421 153,920 19.40% 55,157 6.95%
7 549,444 132,275 24.07% 54,996 10.01%
8 300,197 83,798 27.91% 37,273 12.42%
9 251,958 62,201 24.69% 27,124 10.77%
10 316,557 118,145 37.32% 48,733 15.39%
11 458,573 147,068 32.07% 32,952 7.19%
12 320,577 70,851 22.10% 35,688 11.13%
CARAGA 210,595 71,542 33.97% 28,439 13.50%
BARMM 112,311 19,457 17.32% 7,644 6.81%
PHIL 8,493,663 2,781,196 32.74% 1,263,049 14.87%


As of July 20, 2021, a total of 2,781,196 senior citizens (Group A2) received their first dose of vaccine
against COVID-19. Of which 1,555,908 were vaccinated with Sinovac, 923,528 individuals received
AstraZeneca, 25,650 were given Gamaleya, 267,156 were given Pfizer, 8,954 were given Moderna, and
538 were given Janssen J&J (Table 4). On the other hand, 3,491,823 individuals under Group A3 (with
comorbidities) have been vaccinated with 1st dose of vaccine against COVID-19. Of which, 2,074,667
Sinovac, 739,428 Astrazeneca, 83,644 Gamaleya, 586,551 Pfizer, 7,533 Moderna, and 657 Janssen
J&J vaccines were administered to individuals belonging to such group (Table 5).
Table 5. Vaccination Coverage for Sinovac, AstraZeneca, Gamaleya, Pfizer, and Moderna Vaccine (First Dose and Second Completed Dose)
for Estimated Eligible Population Priority A3 as of 20 July 2021, 6 PM

Estimated
REGION (Priority Group
FIRST FIRST COMPLETED COMPLETED
A3)
NCR To be finalized 1,415,099 -- 975,404 --

CAR 118,174 54,554 46.16% 28,480 24.10%
1 347,468 60,849 17.51% 18,180 5.23%
2 241,319 96,816 40.12% 34,127 14.14%
3 836,289 313,077 37.44% 90,850 10.86%
4A 1,083,239 429,027 39.61% 146,521 13.53%
Mimaropa 191,237 44,414 23.22% 15,652 8.18%
5 368,036 38,252 10.39% 9,530 2.59%
6 520,938 183,199 35.17% 59,609 11.44%
7 517,662 281,670 54.41% 78,120 15.09%
8 292,606 63,883 21.83% 18,659 6.38%
9 235,595 95,969 40.73% 33,620 14.27%
10 321,128 105,859 32.96% 46,602 14.51%
11 340,850 164,064 48.13% 65,400 19.19%
12 308,726 53,270 17.25% 16,030 5.19%
CARAGA 169,528 65,714 38.76% 20,520 12.10%
BARMM 231,901 26,107 11.26% 6,710 2.89%
PHIL 7,085,183 3,491,823 49.28% 1,664,014 23.49%


As of July 20, 2021, a total of 2,023,421 frontline personnel in essential sectors both in public and
private sectors (Group A4) received their first dose of vaccine against COVID-19. Of which 1,724,069
were vaccinated with Sinovac, 199,160 with Astrazeneca, 54,616 with Gamaleya, 18,901 with Pfizer, and
26,675 with Moderna (Table 6). The vaccination roll-out for Priority Group A4 commenced this June
2021.
Table 6. Vaccination Coverage for Sinovac, AstraZeneca, Gamaleya, Pfizer, and Moderna Vaccine (First Dose and Second Completed Dose) for
Estimated Eligible Population Priority A4 as of 20 July 2021, 6 PM

Estimated
REGION (Priority
FIRST FIRST COMPLETEDCOMPLETED
Group A4) DOSE 2 DOSES
DOSE 2 DOSES
NCR 3,717,251 1,393,947 37.50% 531,859 14.31%

CAR 482,651 11,047 2.29% 489 0.10%
1 1,346,591 4,266 0.32% 108 0.01%
2 983,617 6,262 0.64% 446 0.05%
3 3,209,598 104,823 3.27% 9,801 0.31%
4A 4,467,831 286,104 6.40% 12,402 0.28%
Mimaropa 760,880 4,875 0.64% 2,452 0.32%
5 1,487,494 10,896 0.73% 2,954 0.20%
6 1,991,541 48,811 2.45% 4,787 0.24%
7 2,069,219 4,314 0.21% 0 --
8 1,102,953 16,860 1.53% 4,251 0.39%
9 931,227 9,924 1.07% 1,157 0.12%
10 1,357,267 17,143 1.26% 107 0.01%
11 1,370,308 88,017 6.42% 2,443 0.18%
12 1,265,643 1,903 0.15% 0 --
CARAGA 659,370 3,710 0.56% 17 --
BARMM 903,549 10,519 1.16% 3,947 0.44%
PHIL 28,106,990 2,023,421 7.20% 577,220 2.05%
**Based on NEDA’s revised estimated number of Priority Group A4 disaggregated by region (took into consideration the overlaps
with Priority Group A2). As per NEDA, due to data limitations earlier this year, overlaps with A1 and A3 have not yet been
addressed in this computation.


As of July 20, 2021, a total of 379,289 poor population (Group A5) received their first dose of vaccine
against COVID-19. Of which 102,721 were vaccinated with Sinovac, 37,754 were given Astrazeneca, 5,479
were given Gamaleya, 225,933 with Pfizer, and 7,402 with Moderna (Table 7).
Table 7. Vaccination Coverage for Sinovac, Astrazeneca, Pfizer, and Moderna Vaccine (First Dose and Second Completed Dose) for Estimated
Eligible Population Priority A5 as of 20 July 2021, 6 PM

Estimated
REGION (Priority
FIRST FIRST COMPLETED COMPLETED
Group A5)
NCR 663,588 328,627 49.5% 185,187 27.91%

CAR 179,565 1,575 0.9% 294 0.16%
1 618,150 0 -- 0 --
2 315,918 3 -- 0 --
3 882,423 545 0.1% 7 --
4A 955,143 33,000 3.5% 2,745 0.29%
Mimaropa 583,026 0 -- 0 --
5 1,111,587 800 0.1% 278 0.03%
6 967,299 2,888 0.3% 275 0.03%
7 854,691 5 -- 0 --
8 839,772 2,651 0.3% 1,249 0.15%
9 896,151 332 -- 15 --
10 798,837 10 -- 0 --
11 771,534 8,175 1.1% 674 0.09%
12 743,511 0 -- 0 --
CARAGA 566,586 678 0.1% 0 --
BARMM 1,163,412 0 -- 0 --
PHIL 12,911,193 379,289 2.94% 190,724 1.48%
As of 20 July 2021 6PM, a total of 10,585,261 doses of COVID-19 vaccines have been administered as
first dose of either Sinovac, AstraZeneca, Gamaleya, Pfizer, and Moderna. A cumulative number of
1,584,497 healthcare workers, 325,035 expanded priority group A1, 2,781,196 senior citizens,
3,491,823 individuals with comorbidities, 2,023,421 frontline personnel in essential sectors both in
public and private sectors, and 379,289 poor population were given the first dose of vaccines.
On the other hand, a total of 5,031,301 doses of COVID-19 vaccines have been administered as second
dose of either Sinovac, AstraZeneca, Gamaleya, and Pfizer. A cumulative number of 1,260,503 health
care workers, 75,791 expanded priority group A1, 1,263,049 senior citizens, 1,664,014 individuals
with comorbidities, 577,220 frontline personnel in essential sectors both in public and private sector
and 190,724 poor population were give their second dose of vaccines. This shows weekly increase of
coverage per priority group [Figure 4].


Figure 4. Number of Cumulative Vaccinated (First and Second Doses) Eligible Priority Groups, as of 20 July 2021, 6 PM
There are a total of 50,627 reported suspected AEFI cases as of 20 July 2021, 6PM. 20,387 of which
are under Sinovac (19,761 are non-serious AEFIs while 626 cases are serious AEFIs). For AstraZeneca,
27,898 vaccinees experienced AEFIs (27,358 of which are non-serious AEFIs and 540 serious AEFIs). For
Gamaleya Sputnik V, 583 vaccinees experienced AEFIs (576 are non-serious and 7 serious). For Pfizer
Comirnaty, 1,585 vaccinees experienced AEFIs (1,529 non-serious and 56 serious). On the other hand,
174 vaccinees experienced AEFIs (170 non-serious and 4 serious) for Moderna.
The regions with the highest number of AEFIs reported under Sinovac are NCR (4,439), Region 7 (2,884)
and Region 4A (2,311) [Figure 5]. The regions with the highest number of reported AEFIs under
Astrazeneca are NCR (5,560), Region 4A (3,936) and Region 3 (2,628) as of the said date [Figure 6].
There were 530 reported AEFI cases in NCR, 2 in CAR, 1 in Region 2, 4 in Region 3, 7 in Region 4A, 3
in Region 4B, 18 in Region 9, 3 in Region 10, and 15 in Region 11 since the start of inoculation of
Gamaleya Sputnik V vaccine. There were 421 reported AEFI cases for Pfizer Comirnaty in NCR, 13 in
CAR, 5 in Region 1, 5 in Region 2, 77 in Region 3, 240 in Region 4A, 9 in Region 6, 400 in Region 7,
20 in Region 9, 10 in Region 10, and 385 in Region 11. There were 166 reported AEFI cases for Moderna
in NCR, 3 in Region 3, 4 in Region 4A, and 1 in Region 7.


Figure 5. Distribution of Reported AEFIs to Sinovac per Region, as of 20 July 2021, 6PM (n=20,387)
Figure 6. Distribution of Reported AEFIs to AstraZeneca per Region, as of 20 July 2021, 6PM (n=27,898)


As of 21 July 2021 6AM, a total of 25,951,560 doses of vaccines arrived in the Philippines since the start
of the campaign, which comprised of 13,600,000 Sinovac, 5,944,100 Astrazeneca, 350,000 Gamaleya,
2,472,210 Pfizer, 344,400 Moderna, and 3,240,850 doses of Janssen J&J vaccines. Further, 90.13%
vaccines were already distributed to the different regions and implementing units (Table 8).
Table 8. Distribution of Sinovac, AstraZeneca, Gamaleya, Pfizer, and Moderna Vaccines to Regions and Implementing Units as of 21 July
2021, 6 AM
Vaccine Total Delivered

SINOVAC ASTRAZENECA GAMALEYA PFIZER MODERNA JANSSEN J&J
Brand Vaccines
REGION
NCR 4,848,850 1,832,290 177,900 1,147,770 136,200 100,000 8,243,010
CAR 211,160 89,400 5,700 35,100 0 100,000 441,360
1 348,400 224,700 24,300 35,100 0 206,600 839,100
2 320,160 184,600 13,200 19,890 0 13,000 550,850
3 961,680 674,500 13,200 228,150 5,000 0 1,882,530
4A 1,465,620 875,580 34,500 408,330 1,000 339,000 3,124,030
Mimaropa 226,400 113,700 8,100 0 0 38,050 386,250
5 305,480 113,700 2,400 0 0 175,400 596,980
6 646,160 337,800 4,800 33,930 0 289,900 1,312,590
7 613,200 347,600 10,700 242,190 0 203,850 1,417,540
8 361,010 167,000 2,400 2,340 0 131,200 663,950
9 293,440 131,400 8,100 35,100 0 109,200 577,240
10 363,000 172,800 23,100 35,100 0 128,300 722,300
11 506,560 365,620 12,000 239,850 0 143,850 1,267,880
12 261,020 140,700 2,400 0 0 153,700 557,820
CARAGA 243,940 108,400 2,400 0 0 130,000 484,740
BARMM 131,760 39,500 0 0 0 150,000 321,260
PHIL 12,107,840 5,919,290 345,200 2,462,850 142,200 2,412,050 23,389,430
Disclaimer: Partial logistics data for Moderna vaccines.
Prepared by:
KEZIA LORRAINE H. ROSARIO, MD, MPM, RN

Secretariat, National Vaccination Operations Center
Department of Health
Approved by:
MYRNA C. CABOTAJE, MD, MPH, CESO III

Chair, National Vaccination Operations Center
Undersecretary of Health, Field Implementation and Coordination Team
Department of the Health


COVID-19 Vaccine Daily Bulletin No. 140

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

COVID-19 Vaccine Daily Bulletin No. 140

Uploaded by

Copyright:

Available Formats

NATIONAL COVID-19 VACCINATION OPERATIONS CENTER

AFP Commissioned Officers Club House, Camp Aguinaldo

TOTAL DOSES 15,616,562

1ST 2,781,196 2,023,421 379,289 10,585,261

As of 20 July 2021, a total of 15,616,562 doses of COVID-19 vaccines

There were 284,441 total doses of COVID-19 vaccines administered on

Disclaimer: Counts are NOT absolute and are subject to change

PHILIPPINES COVID-19 VACCINE DEPLOYMENT AND VACCINATION CAMPAIGN As of 20 July 2021 1

Disclaimer: Counts are NOT absolute and are subject to change

PHILIPPINES COVID-19 VACCINE DEPLOYMENT AND VACCINATION CAMPAIGN As of 20 July 2021 2

NCR 301,749 290,324 96.21% 257,208 85.24%

Disclaimer: Counts are NOT absolute and are subject to change

PHILIPPINES COVID-19 VACCINE DEPLOYMENT AND VACCINATION CAMPAIGN As of 20 July 2021 3

Total Overall Total Overall

NCR 1,133,317 694,658 61.29% 460,835 40.66%

Disclaimer: Counts are NOT absolute and are subject to change

PHILIPPINES COVID-19 VACCINE DEPLOYMENT AND VACCINATION CAMPAIGN As of 20 July 2021 4

Total Overall Total Overall

NCR To be finalized 1,415,099 -- 975,404 --

Disclaimer: Counts are NOT absolute and are subject to change

PHILIPPINES COVID-19 VACCINE DEPLOYMENT AND VACCINATION CAMPAIGN As of 20 July 2021 5

Total Overall Total Overall

NCR 3,717,251 1,393,947 37.50% 531,859 14.31%

Disclaimer: Counts are NOT absolute and are subject to change

PHILIPPINES COVID-19 VACCINE DEPLOYMENT AND VACCINATION CAMPAIGN As of 20 July 2021 6

Total Overall Total Overall

NCR 663,588 328,627 49.5% 185,187 27.91%

Disclaimer: Counts are NOT absolute and are subject to change

PHILIPPINES COVID-19 VACCINE DEPLOYMENT AND VACCINATION CAMPAIGN As of 20 July 2021 7

Disclaimer: Counts are NOT absolute and are subject to change

PHILIPPINES COVID-19 VACCINE DEPLOYMENT AND VACCINATION CAMPAIGN As of 20 July 2021 8

Disclaimer: Counts are NOT absolute and are subject to change

PHILIPPINES COVID-19 VACCINE DEPLOYMENT AND VACCINATION CAMPAIGN As of 20 July 2021 9

Vaccine Total Delivered

Disclaimer: Partial logistics data for Moderna vaccines.

KEZIA LORRAINE H. ROSARIO, MD, MPM, RN

MYRNA C. CABOTAJE, MD, MPH, CESO III

Disclaimer: Counts are NOT absolute and are subject to change

PHILIPPINES COVID-19 VACCINE DEPLOYMENT AND VACCINATION CAMPAIGN As of 20 July 2021 10

You might also like